|
USA-CA-LOSANGELES Azienda Directories
|
Azienda News:
- The trouble with antidepressants: why the evidence overplays benefits . . .
Widespread prescribing has not reduced mental disability or suicide, raising questions about the assessment of evidence on effectiveness and safety of antidepressants, writes John Warren Depression can be severe and reduce life expectancy
- The trouble with antidepressants: why the evidence overplays benefits . . .
Surveys of antidepressant users suggest that 30% to 50% of long-term antidepressant prescriptions had no evidence-based indication Unnecessary use of antidepressants puts people at risk
- The trouble with antidepressants: why the - ProQuest
A common justification for using antidepressants is that they correct a chemical deficiency in the brain The monoamine hypothesis, over 50 years old, implicates serotonergic, noradrenergic, and dopaminergic neurotransmission in the pathogenesis of depression
- Warren, J. B. (2020). The Trouble with Antidepressants Why the Evidence . . .
Research evidence indicates that transcranial direct current stimulation (tDCS) can reduce symptoms of depression Flow FL-100 is a tDCS device self-administered by a patient at home in combination with a software application-delivered wellbeing behaviour therapy training
- The trouble with antidepressants: why the evidence overplays benefits . . .
The trouble with antidepressants: why the evidence overplays benefits and underplays risks-an essay by John B Warren BMJ 2020 Sep 3;370:m3200 doi: 10 1136 bmj m3200
- John B. Warren – A New Vision for Mental Health
The trouble with antidepressants: why the evidence overplays benefits and underplays risks Author: Editorial 18th September 2020 0 Comments “Widespread prescribing has not reduced mental disability or suicide, raising questions about the assessment of evidence on effectiveness and safety of antidepressants” This essay by John B Warren has
- Beneficial and harmful effects of antidepressants versus placebo . . .
The present systematic review aims at forming the basis for evidence-based guideline recommendations for the use of antidepressants for major depressive disorder taking bias risks (systematic errors), play of chance (random errors), and certainty of the findings into consideration
- New NICE guideline: antidepressants and chronic pain — chicken or egg . . .
(2020) The trouble with antidepressants: why the evidence overplays benefits and underplays risks — an essay by John B Warren BMJ 370, m3200
- Beneficial and harmful effects of antidepressants versus placebo . . .
The present systematic review aims at forming the basis for evidence-based guideline recommendations for the use of antidepressants for major depressive disorder taking bias risks (systematic errors), play of chance (random errors), and certainty of the findings into consideration
- The risks of adverse events with venlafaxine and mirtazapine versus . . .
Therefore, we aim to investigate the risks of adverse events with venlafaxine or mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder in two separate systematic reviews
|
|